CSIEX
Price
$80.42
Change
-$0.65 (-0.80%)
Updated
Jul 11 closing price
Net Assets
5.86B
GFACX
Price
$70.62
Change
-$0.29 (-0.41%)
Updated
Jul 11 closing price
Net Assets
322.6B
Interact to see
Advertisement

CSIEX vs GFACX

Header iconCSIEX vs GFACX Comparison
Open Charts CSIEX vs GFACXBanner chart's image
Calvert Equity A
Price$80.42
Change-$0.65 (-0.80%)
VolumeN/A
Net Assets5.86B
American Funds Growth Fund of Amer C
Price$70.62
Change-$0.29 (-0.41%)
VolumeN/A
Net Assets322.6B
CSIEX vs GFACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CSIEX vs. GFACX commentary
Jul 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSIEX is a Buy and GFACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 323B vs. CSIEX (5.86B). CSIEX pays higher dividends than GFACX: CSIEX (0.16) vs GFACX (0.00). CSIEX was incepted earlier than GFACX: CSIEX (38 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than CSIEX (0.90). GFACX is a more actively managed with annual turnover of: 25.00 vs. CSIEX (9.00). GFACX has a lower initial minimum investment than CSIEX: GFACX (250) vs CSIEX (1000). GFACX annual gain was more profitable for investors over the last year : 8.06 vs. CSIEX (-1.39). CSIEX return over 5 years is better than : 37.70 vs. GFACX (34.23).
CSIEXGFACXCSIEX / GFACX
Total Expense Ratio0.901.3666%
Annual Report Gross Expense Ratio0.901.3666%
Fund Existence38 years24 years-
Gain YTD4.96010.75946%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets5.86B323B2%
Annual Yield % from dividends0.160.00-
Returns for 1 year-1.398.06-17%
Returns for 3 years23.3253.0644%
Returns for 5 years37.7034.23110%
Returns for 10 years58.3264.1691%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BDSX0.31N/A
+1.05%
Biodesix
XTLB1.51-0.01
-0.66%
XTL Biopharmaceuticals Ltd
LCII100.17-1.01
-1.00%
LCI Industries
BSBR5.03-0.07
-1.37%
Banco Santander (Brasil) SA
IREN16.23-0.80
-4.70%
IREN Limited